Eduardo Nava

Dr. Eduardo Nava

University of Castilla La Mancha School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1992 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
RSR. Schulz
R. Schulz
Eduardo NavaEduardo Nava
Eduardo Nava
SMS. Moncada
S. Moncada
We have investigated whether the myocardium and isolated cardiac myocytes can express a Ca2+‐independent NO synthase after treatment with endotoxin or cytokines. Nitric oxide synthesis was measured in cytosols from the left ventricular wall from rats treated with endotoxin, or from freshly isolated myocytes from adult rats treated in vitro with cytokines. Cytosols from the ventricle of saline‐treated control animals showed only Ca2+‐dependent NO synthesis. After treatment with endotoxin, the expression of an inducible, Ca2+‐independent NO synthase was observed. The activity of this enzyme was maximal at 6 h and returned towards control levels by 18 h; no alterations occurred in the Ca2+‐dependent NO synthase activity. Parallel to this enzyme induction there was an increase in myocardial guanosine 3′:5′‐cyclic monophosphate (cyclic GMP) and plasma nitrite and nitrate (NO−x). All these changes were prevented by pretreatment of the rats with dexamethasone. Myocytes possessed Ca2+‐dependent NO synthase activity and expressed, after treatment with tumour necrosis factor‐α (TNF‐α) and interleukin‐1β (IL‐1β), a Ca2+‐independent NO synthase, the induction of which was prevented by dexamethasone and cycloheximide. Since increases in cyclic GMP levels in the heart are associated with reduced myocardial contractility, it is possible that the enhanced production of NO by a Ca2+‐independent enzyme accounts, at least in part, for the depression of myocardial contractility seen in septic shock, cardiomyopathies, allograft rejection, burn trauma, as well as during anti‐tumour therapy with cytokines.

1 December 1991 in The Lancet
Verified
Journal Article
Closed access
Eduardo NavaEduardo Nava
Eduardo Nava
RPR.M.J. Palmer
R.M.J. Palmer
SMS. Moncada
S. Moncada

1 April 1992 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
Eduardo NavaEduardo Nava
Eduardo Nava
RPR. M. J. Palmer
R. M. J. Palmer
SMS. Moncada
S. Moncada
The role of nitric oxide (NO) in the changes in blood pressure and plasma levels of nitrate and nitrite (NOx) and alanine aminotransferase (ALT) were determined over a 5-h period in anesthesized rats after intravenous administration of S. typhosa endotoxin (LPS, 4 mg/kg). Rats treated with LPS showed a sustained fall in blood pressure accompanied by an increase in plasma NOx and ALT. Forty percent of these rats died during the experiment. There was no change in blood pressure in rats treated with dexamethasone (1 mg/kg) 1 h before and 2 h after LPS and the increase in NOx and ALT was significantly inhibited. None of the rats in this group died. Administration of 10 mg/kg of NG-monomethyl-L-arginine (L-NMMA) prevented the fall in blood pressure and partially prevented the increase in NOx and ALT. None of the animals in this group died. In contrast, 300 mg/kg of L-NMMA caused an initial increase in blood pressure followed by a rapid fall and enhanced the increase in ALT while abolishing the elevation of NOx. All of these animals died before the end of the experiment. However, when rats treated with high doses of L-NMMA were given a continuous infusion of S-nitroso-N-acetylpenicillamine (SNAP, 300 micrograms/kg/h), the blood pressure was maintained at control levels and no mortality was observed.(ABSTRACT TRUNCATED AT 250 WORDS)

1 May 1995 in Circulation
Verified
Journal Article
Closed access
PDF file
Eduardo NavaEduardo Nava
Eduardo Nava
GNGeorg Noll
Georg Noll
TLThomas F. LüsCher
Thomas F. LüsCher
BackgroundWe analyzed the activity of nitric oxide synthase in the rat heart to study whether this activity is affected by high blood pressure. Hearts from young (3 to 4 weeks old) and adult (15 to 25 weeks old) Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) were excised and frozen in liquid nitrogen. The activities of Ca2+-dependent (cNOS) and Ca2+-independent (iNOS) were determined in homogenized tissues by measuring the conversion of [14C]-l-arginine to [14C]-l-citrulline in the presence or absence of either EGTA (1 mmol/L) or EGTA plusNG-nitro-l-arginine methyl ester (L-NAME, 1 mmol/L each).Methods and ResultsArterial pressure was higher in adult SHR than in young SHR and WKY rats of both ages (P<.01). The cNOS activity was two to three times higher in hypertensive than in normotensive hearts (P=.01 toP=.04). No significant activity of iNOS was detected in any tissue. Studies of the right and left ventricles demonstrated a higher cNOS activity in the left sides of the hearts of adult SHR (P<.05). No differences were found in hearts from WKY rats. Selective removal of endocardial or coronary endothelial cells in hearts of SHR and WKY rats substantially reduced cNOS activity (P<.01).ConclusionsThe cNOS activity is upregulated in cardiac endothelial cells of genetically hypertensive rats. The high activity of cardiac cNOS is related to increased arterial pressure of these animals. We propose that in the heart, endothelial cells respond with a higher production of nitric oxide as a compensatory mechanism against high blood pressure and its damaging effects in this organ.

1 January 2013 in International Journal of Hypertension
Verified
Journal Article
Open access
PDF file
YMYolanda Mendizábal
Yolanda Mendizábal
Sílvia LlorensSílvia Llorens
Sílvia Llorens
Eduardo NavaEduardo Nava
Eduardo Nava
Metabolic syndrome is a cluster of metabolic and cardiovascular symptoms: insulin resistance (IR), obesity, dyslipemia. Hypertension and vascular disorders are central to this syndrome. After a brief historical review, we discuss the role of sympathetic tone. Subsequently, we examine the link between endothelial dysfunction and IR. NO is involved in the insulin-elicited capillary vasodilatation. The insulin-signaling pathways causing NO release are different to the classical. There is a vasodilatory pathway with activation of NO synthase through Akt, and a vasoconstrictor pathway that involves the release of endothelin-1 via MAPK. IR is associated with an imbalance between both pathways in favour of the vasoconstrictor one. We also consider the link between hypertension and IR: the insulin hypothesis of hypertension. Next we discuss the importance of perivascular adipose tissue and the role of adipokines that possess vasoactive properties. Finally, animal models used in the study of vascular function of metabolic syndrome are reviewed. In particular, the Zucker fatty rat and the spontaneously hypertensive obese rat (SHROB). This one suffers macro- and microvascular malfunction due to a failure in the NO system and an abnormally high release of vasoconstrictor prostaglandins, all this alleviated with glitazones used for metabolic syndrome therapy.

1 January 1996 in Hypertension
Verified
Journal Article
Closed access
PDF file
HTHiroyuki Takase
Hiroyuki Takase
PMPierre Moreau
Pierre Moreau
CKChristoph F. KünG
Christoph F. KünG
Eduardo NavaEduardo Nava
Eduardo Nava
TLThomas F. LüsCher
Thomas F. LüsCher
The objective of this study was to examine the effects of long-term antihypertensive therapy on blood pressure and vascular responses of resistance arteries during prolonged inhibition of nitric oxide synthesis. Four groups of 6-week-old Wistar-Kyoto rats were treated with either placebo as controls orNω-nitro-l-arginine methyl ester (L-NAME) alone or in combination with verapamil or with trandolapril. Drugs were given orally for 6 weeks or short-term in vitro to vessels obtained from untreated rats. Endothelium-dependent and -independent relaxations as well as contractions were studied in isolated perfused mesenteric and renal arteries with an arteriograph. Kidney nitric oxide synthase activity was also evaluated. Verapamil and trandolapril prevented the increase in systolic blood pressure and the blunted acetylcholine-induced relaxations that occurred with L-NAME treatment without improving the nitric oxide synthase activity. Both antihypertensive regimens also normalized sensitivity to sodium nitroprusside, which was enhanced by L-NAME. In contrast, short-term in vitro preincubation with verapamil or trandolaprilat in the presence of L-NAME did not improve the impaired relaxations to acetylcholine. Long-term but not short-term therapy with a calcium antagonist or angiotensin-converting enzyme inhibitor improved the blunted endothelium-dependent relaxations in nitric oxide–deficient hypertension. These findings strongly suggest that the role of other vasodilator systems, which normally do not regulate vascular tone, is enhanced with long-term but not short-term treatment with these drugs. These observations emphasize the potential importance of these treatments in the management of hypertension in which nitric oxide production is diminished.